PHARMACY

Impax launches authorized Solodyn generic

BY David Salazar

Impax Labs has launched its authorized Solodyn generic (minocycline HCl, extended-release tablets). The drug is indicated to treat only inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients ages 12 years and older.

Impax’s authorized Solodyn generic will be available in 65- and 115-mg dosage strength. The product had U.S. sales of roughly $148 million for the 12 months ended December 2017, according to IQVIA data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
Amneal's generic Namenda XR
PHARMACY

Amneal’s generic Namenda XR introduced

BY David Salazar

Amneal’s generic Namenda XR (memantine hydrochloride extended release) capsules have launched in four dosage strengths. The drug is indicated for the treatment of moderate-to-sever dementia of the Alzheimer’s type.

Amneal’s generic Namenda XR will be available in 7-, 14-, 21- and 28-mg dosage strengths. The product had U.S. sales of roughly $929 million for the 12 months ended December 2017, according to IQVIA data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
Teva generic Solodyn
PHARMACY

Teva launches generic Solodyn

BY DSN STAFF

Teva has introduced its generic Solodyn (minocycline HCl). The drug is indicated to treat inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients ages 12 years and older.

Teva’s generic Solodyn will be available in 65- and 115-mg dosage strengths.

“The launch of these two strengths of our generic version of Solodyn brings an effective, affordable treatment option to patients who are managing this condition, and marks our ninth generic medicine in the tetracycline category,” Teva executive vice president and head of North American commercial Brendan O’Grady said.

The product had U.S. sales of roughly $148 million for the 12 months ended December 2017, according to IQVIA data.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?